This review centers on the possible role of GABA~A~ receptors (GABA~A~R) and the scaffolding protein gephyrin in epileptogenesis. The basic premise is that disruption of the network of proteins involved in the trafficking and anchoring of GABA~A~R might result in decreased inhibitory drive, which may promote the development of spontaneous seizures. A brief introduction to epilepsy and epileptogenesis is provided along with some of the fundamental aspects of the regulation of GABA~A~R by gephyrin. Finally an overview of the alterations in gephyrin and GABA~A~R function observed during epileptogenesis is included.

EPILEPTOGENESIS AND EPILEPSY
============================

In the majority of patients, temporal lobe epilepsy (TLE) appears to be the result of an injury to the brain caused by trauma, febrile seizures, encephalitis, or status epilepticus (SE; [@B11]; [@B64]). The precise point in time when spontaneous seizures appear is unknown but it is suspected that following a brain injury there is a pre-epileptic state when many changes occur and transform a normal brain into an epileptic one. Since in many cases, after a brain injury, patients recover from a triggering injury without presenting overt spontaneous seizures, the period that precedes the appearance of recurrent epileptic seizures is known as latent or silent period ([@B64]; [@B56]). During the early stages of the chronic period spontaneous seizures are more likely to be controlled with medication but as the disease progress seizures become less responsive to medication and might become intractable ([@B77]). So far there is a consensus that acquired epilepsy results from a triggering insult to the brain and that the cellular and molecular alterations resulting from such insult play a key role in the development of epilepsy, but a direct link between the brain abnormalities detected in epileptic tissue and the generation of recurrent spontaneous seizures remains to be firmly established.

Due to the inherent or obvious limitations associated with the acquisition of human samples, the mechanisms responsible for the appearance of spontaneous seizures are being aggressively studied in experimental models of epilepsy. Post-SE models of chronic epilepsy closely mimic the clinical manifestations and tissue abnormalities observed in humans affected with TLE ([@B64]; [@B9]; [@B47]). Induction of SE in rodents by systemic or local administration of a chemoconvulsant is usually followed by a silent (latent) period lasting days or weeks when no obvious seizure activity is observed. During the latent period brain abnormalities develop and inter-ictal activity becomes more frequent, and then suddenly with no apparent cause overt spontaneous seizures manifest ([@B9]; [@B63]). To capitalize the methodological advantages provided by the experimental models, several laboratories have attempted to characterize and establish the duration of the latent (silent) period, unfortunately these attempts have yielded a wide range of measures ([@B78]). It appears that despite the advantages provided by a well-controlled experimental setting, the animals used in the experiments and the type and severity of injury being tested might impact the length of the latent period. More importantly, some methodological limitations (i.e., accuracy of seizure detection, continuous vs. intermittent monitoring, authentication of when the first seizure occurred, etc.) directly impact the accuracy of the measurements and need to be overcome in order to obtain a definitive characterization of the latent period ([@B78]).

The dynamic process characterized by progressive alterations in neuronal excitability that promotes appearance of spontaneous seizures and its associated structural lesions is known as epileptogenesis ([@B60]). Currently, the terms epileptogenesis and latent (or silent) period are used interchangeably to describe the period that encompass the occurrence of an insult to the brain and the appearance epileptic seizures. However, recent findings in patients and experimental models suggest that the alterations resulting from an injury to the brain might progress beyond the appearance of the first spontaneous seizure. Accordingly, it has been suggested that during the natural evolution of epilepsy, each new episode of spontaneous seizures (an insult itself) produces new damage that compounds the damage produced by the original brain injury ([@B78]; [@B65]; [@B59]; [@B56]). Many cellular and molecular alterations in both neuronal and non-neuronal cells have been observed during epileptogenesis. Neuronal alterations include neurodegeneration, neurogenesis, and axonal damage in addition to the architectural reorganization of neuronal processes that result from abnormal sprouting and altered dendritic plasticity. Astrocytes become hypertrophic, develop longer and thicker processes and increase the expression of glial fibrillary acidic protein all as part of a process known as reactive astrogliosis ([@B19]; [@B24]; [@B40]). During epileptogenesis there are many pathological processes that affect brain excitability including the breakdown of the blood--brain barrier (BBB) and inflammation. Ultrastructural analysis of epileptic tissue revealed significant abnormalities in the BBB components and focal opening of the BBB by direct application of albumin can lead to the generation of an epileptic focus ([@B28]; [@B73]; [@B24]). Further, the magnitude of BBB leakage occurring during epileptogenesis has been shown to directly correlate with the seizure frequency detected during the chronic period ([@B72]; [@B74]). Inflammatory response due to activation of microglia and astrocytes is associated with brain damage and increased BBB permeability in the tissue adjacent to the region of injury ([@B73]; [@B51]). SE-induced inflammation is observed during the epileptogenic period and appears to be reactivated by the occurrence of spontaneous seizures, suggesting that inflammation might have a role in epileptogenesis and promote epileptic activity during the chronic period due to the continuous presence of inflammation intermediaries ([@B73], [@B74]).

GABA~A~ RECEPTORS AND ITS ASSOCIATED PROTEINS
=============================================

The majority of fast inhibitory neurotransmission in the mature brain is mediated by anion-selective GABA~A~R that are assembled as pentamers from an array of multiple subunit subtypes including α1--2, β1--3, γ1--3, δ, ε, π, θ, and σ1--3 ([@B16]; [@B31]; [@B48]; [@B1]). The subunit composition of GABA~A~R governs the intrinsic properties of the channel such as affinity for GABA, receptor kinetics, conductance, and allosteric modulation. In addition, intracellular loops of each subunit have the potential to interact with scaffolding proteins and affect the cellular distribution and clustering (synaptic or extrasynaptic) of the channels ([@B31]; [@B48]; [@B1]). GABA~A~R assembled by combining γ2 and α1--3 subunits (α1--3,βx,γ2) are more commonly located at synaptic sites and mostly responsible for phasic inhibition, whereas receptors located at perisynaptic or extrasynaptic sites are primarily composed of α4 or α6 subunits combined with δ subunits (α4/α6,βx,δ) and mediate most tonic inhibition ([@B16]; [@B31]; [@B48]; [@B26]). Notably, tonic currents in pyramidal neurons of the hippocampus can also be generated by receptors containing α5 subunits (α5βγ2) that are located at extrasynaptic locations ([@B1]; [@B26]).

Typically, following synthesis in the endoplasmic reticulum, GABA~A~R are delivered to extrasynaptic compartments within the plasma membrane and then diffuse toward its final destination in either synaptic or extrasynaptic locations. GABA~A~R located at the plasma membrane also transit among different cellular compartments due to internalization and recycling events. Thus, the final number of receptors located at the cell surface is determined by continuous insertion of *de novo* synthesized and recycled receptors ([@B54]; [@B41]). There are a number of accessory proteins that facilitate the transit of GABA~A~R along the biosynthetic pathway and the different recycling compartments within the cell ([@B6]; [@B31]; [@B41]). Early on, during GABA~A~R oligomerization, accessory proteins like BIP (heavy chain binding protein), calnexin and BIG2 (Brefeldin-A-inhibited GDP/GTP exchange factor 2) form interactions with the nascent receptors within the membranous compartments of the endoplasmic reticulum and help with the translocation of the receptors into the Golgi apparatus. During the vesicular trafficking of receptors toward the plasma membrane, GABA~A~R containing γ subunits are linked to tubulin and the microtubules by GABARAP (GABA~A~R-associated protein) that acts as a bridge between vesicles containing GABA~A~R and the machinery that moves those vesicles toward the plasma membrane. GABARAP can also bind to NSF (*N*-ethylmaleimide-sensitive factor), PRIPs (phospholipase-C-related catalytically inactive proteins) and GRIF (GABA~A~R-interacting factors also known as TRAK), and together these proteins promote the interaction of intracellular vesicles containing GABA~A~R with the cytoskeleton and facilitate the motor-dependent transport of receptors toward the plasma membrane ([@B37]; [@B75]; [@B4]). The final destination of GABA~A~R into synaptic or extrasynaptic sites is intrinsically determined by the subunits forming the channels and extrinsically by protein--protein interactions with scaffolding proteins ([@B49]; [@B6]; [@B31]; [@B41]).

Gephyrin is the main structural scaffold that links proteins located at the subsynaptic compartment with the cytoskeleton and it is required for the organization and clustering of GABA~A~R at inhibitory synapses ([@B54]; [@B17]). During development, increased concentration of gephyrin precedes the accumulation of GABA~A~R at synaptic sites and facilitates the formation and stabilization of inhibitory synapses ([@B8]; [@B10]; [@B67]; [@B17]). Removal of gephyrin by gene targeting or siRNA interference strongly affects GABA~A~R clustering and reduces inhibitory post-synaptic currents, a reciprocal effect on gephyrin clustering and GABAergic innervations has been observed following elimination of γ2 subunits ([@B13]; [@B36]; [@B44]; [@B79]). GABA~A~R clustering also occurs in neurons lacking gephyrin, but the clusters formed in these conditions have increased mobility and show less accumulation at inhibitory synapses, which reinforces the notion that gephyrin enhance anchoring of receptors at synaptic sites ([@B43]; [@B30]; [@B80]). GABA~A~R containing α5 subunits are responsible for tonic inhibition and can also be found forming extrasynaptic clusters ([@B3]; [@B46]). A crucial player in α5-containing GABA~A~R clustering is radixin. Both radixin antisense and genetic knockout causes a loss of α5 clusters in hippocampal neurons and hippocampal tissue ([@B46]; [@B38]). Radixin and gephyrin do not interact or colocalize with each other, suggesting that the mechanisms behind radixin and gephyrin-dependent clustering are independent ([@B46]; [@B38]).

The structural and molecular details underlying the regulation of GABA~A~R by gephyrin are starting to emerge. Gephyrin consist of three major domains, a 20-kDa N-terminal domain (G-domain), a 43-kDa C-terminal domain (E-domain), and an 18--21 kDa central domain (C-domain; [@B61]; [@B17]). Trimerization of the G-domain and dimerization of the E-domain appear to be the oligomerization pattern involved in the formation of the hexagonal lattice required for proper formation of inhibitory synapses ([@B66]; [@B61]; [@B17]; [@B70]; [@B25]). In addition to its role in the formation of the gephyrin lattice, the E-domain is the binding site for GABA~A~R ([@B70]) whereas the C-domain binds to several accessory proteins like Pin1 ([@B81]), dynein light chain 1 and 2 ([@B18]; [@B50]) and collybistin ([@B35]). Experiments in recombinant expression systems have demonstrated that collybistin is essential for the distribution and stabilization of gephyrin at post-synaptic sites and that overexpression of selected collybistin domains increases the size and density of gephyrin clusters ([@B35]; [@B7]; [@B71]), suggesting that collybistin aids with the proper clustering of GABA~A~R at synaptic sites by forming a partnership with gephyrin ([@B79]). The small GTPase Cdc42 also binds to the C-domain of gephyrin and works in collaboration with collybistin to help with the translocation of gephyrin toward the plasma membrane ([@B71]). Another protein that interacts with gephyrin and indirectly regulates the post-synaptic trafficking and/or accumulation of GABA~A~R is termed GRIP1 (glutamate receptor interacting protein 1). *In vivo* and *in vitro* evidence suggest that GRIP1 is located at GABAergic synapses and physically interacts with gephyrin to directly modulate gephyrin clustering and indirectly regulate the post-synaptic distribution of GABA~A~R ([@B79]).

ALTERATIONS IN GABA~A~R AND SCAFFOLDING PROTEINS DURING EPILEPTOGENESIS
=======================================================================

The belief that following a brain injury there is a quiescent, pre-epileptic state in which there is gradual changes at the molecular, cellular, and circuit levels that ultimately results in the manifestation of spontaneous seizures, has led to the search for mechanisms underlying epileptogenesis. Induction of SE using the chemoconvulsant pilocarpine produces a transient decrease in GABAergic drive readily detectable during the latent period. Abnormal electroencephalogram (EEG) patterns, such as large amplitude spikes and sharp waves can be detected as early as 3--5 days following SE, which overtime culminate with the appearance of full-blown electrographic seizures ([@B12]). During SE there is a rapid increase in neuronal hyperexcitability due to a quick decline in the number of physiologically active GABA~A~R at the plasma membrane ([@B22]; [@B55]). SE triggers a rapid loss of synaptic GABA~A~R containing β and γ subunits while extrasynaptic receptors containing α5 and δ subunits remain unaffected ([@B21]; [@B68]). A decrease in the phosphorylation of β3 subunits allows the interaction of β3-containing GABA~A~R with the clathrin-adaptor protein 2 and the recruitment of GABA~A~R into clathrin-coated pits promotes a faster removal of these receptors from the cell surface, suggesting that a decrease in the phosphorylation of β3 subunits may account for the selective loss of synaptic GABA~A~R observed following SE ([@B21]; [@B68]). These biochemical observations directly link the decrease in miniature inhibitory post-synaptic currents observed after induction of SE with the selective internalization of synaptic GABA~A~R containing β and γ subunits and explain why the currents mediated by extrasynaptic receptors are spared ([@B22]; [@B55]).

The fate of internalized receptors following induction of SE is more likely to be determined by the cellular compartment where they are transiently stored (**Figure [1](#F1){ref-type="fig"}**). Receptors present in endosomal compartments can be reincorporated into the active pool of receptors at the plasma membrane or they can be relocated to the lysosomes for degradation ([@B5]; [@B76]). Recent studies suggest that the network of proteins required for the proper trafficking and anchoring of GABA~A~R might be disrupted following SE. During the latent period there is a reduction in the total expression of gephyrin that appears to translate into a reduction in the number of gephyrin clusters ([@B39]; [@B69]; [@B14]; [@B20]). The pattern of gephyrin loss observed during the silent period parallels the changes in excitability previously observed, and suggests that the loss of scaffolding proteins directly impact the function of GABA~A~R during epileptogenesis. Intriguingly, during the chronic period there is an increase in both the total expression and the number of gephyrin clusters ([@B69]; [@B14]), but it is unclear if this rebound in gephyrin expression results in fully functional inhibitory synapses.

![**Altered stability of GABA~A~R and scaffolding proteins during epileptogenesis.** Induction of *status epilepticus* produces alterations in the expression of gephyrin and might disrupt GABA~A~R anchoring. Decreased expression of gephyrin might compromise the recycling of GABA~A~R and reduce the stability of receptors present at the plasma membrane. Reduced expression of GABA~A~R at the plasma membrane may contribute to the increased excitability observed during epileptogenesis.](fncel-07-00113-g001){#F1}

Alterations in the expression of GABA~A~R during the epileptogenic period include rapid down-regulation of α4, β2/3, γ2, and δ subunits ([@B62]; [@B27]; [@B58]). Our recent characterization of the expression of several GABA~A~R subunits in microdissected CA1 also showed a reduction in the levels of α4, β2/3, and γ2 (but not α1) subunits as early as 4 days after SE ([@B20]). The loss of these subunits correlated with the down-regulation of gephyrin, suggesting that the loss of GABA~A~R might result from the lack of proper receptor anchoring and clustering ([@B20]). Accordingly, analysis of the cell surface levels of GABA~A~R revealed a time-dependent reduction in the plasma membrane levels of α4 and γ2 subunits that correlated with the down-regulation of gephyrin ([@B20]). These observations hint to the possibility that during the epileptogenic period, the stability of the GABA~A~R receptors that recycle back to the plasma membrane might be compromised because they cannot be properly anchored ([@B20]). They also suggest that the loss of inhibition and increased inter-ictal activity observed during the latent period might result from the persistent dysregulation of GABA~A~R trafficking and anchoring ([@B76]). However, whether a loss of scaffolding proteins is a factor contributing to the hyperexcitability observed during the epileptogenic period remains to be fully characterized.

Additional support for hypothesis that a lack of GABA~A~R stability contributes to the hyperexcitability observed during the latent period comes from studies in *Xenopus* oocytes transplanted with cell membranes isolated from epileptic tissue ([@B57]; [@B53]). Repetitive stimulation of microtransplanted receptors induces a characteristic run-down of GABA~A~R-mediated currents that is independent of changes in receptor affinity or membrane potential ([@B57]). The run-down in GABA~A~R currents can be readily detected in receptors isolated following the manifestation of the first spontaneous seizure and its appearance has been associated with the transition from the latent to the chronic stage of epilepsy ([@B53]). Initial exploration of the molecular mechanisms behind this phenomenon revealed a switch in the composition of GABA~A~R and uncovered an increase in the ratio of α4/α1 subunits incorporated into receptors. More importantly, the switch in GABA~A~R assembly occurs at the same time that the current run-down appears, underscoring previous findings showing alterations in the expression of α4 and α1 subunits that affect the assembly, localization, and function of GABA~A~R and results in the impairment of tonic and phasic inhibition ([@B2]; [@B58]; [@B53]).

The specific mechanisms involved in the regulation of gephyrin during epileptogenesis and epilepsy remain to be fully characterized, but some clues are starting to emerge. Analysis of samples obtained from epileptic patients show a reduction in gephyrin expression, which correlates with the appearance of protein fragments probably resulting from gephyrin degradation ([@B15]; [@B14]). The process involved in the generation of gephyrin fragments remains unclear but a favored hypothesis is that cellular stress (alkalosis and hyperthermia) might be sufficient to induce the skipping of exons in gephyrin messenger RNA resulting in the production of abnormally spliced variants of gephyrin. These abnormal variants may then interact with normal gephyrin molecules and act as dominant-negative mutants and promote the accumulation of gephyrin in ubiquitin positive inclusions ([@B15]). The impact abnormally spliced variants of gephyrin has been associated with oligomerization deficits and aberrant clustering of GABA~A~R containing α2 subunits ([@B15]). Induction of mild seizures or inflammatory events triggers the generation of adult-born hippocampal neurons and increases the expression of gephyrin, mostly in the newly generated neurons ([@B33], [@B32]; [@B29]). Electrophysiological recordings revealed that newborn neurons produced after these injuries have reduced excitatory and increased inhibitory drive partially associated with the increase in gephyrin expression. Together, these observations point out to the possibility that newly generated cells might increase gephyrin expression as a compensatory mechanism to mitigate the hippocampal hyperexcitability observed after an insult to the brain ([@B33]; [@B29]).

Another line of evidence implicating gephyrin dysfunction as a key element in the generation of epileptic seizures includes recent genetic evidence found in individuals affected by pathologies associated with a seizure phenotype. Rare hemizygous microdeletions in the chromosome 14q23.3 that encompass exons 3--5 in the coding region the G-domain were found in individuals from six unrelated families presenting autism, schizophrenia, and seizures ([@B45]). Other mutations that interfere with collybistin function have also been associated with abnormalities observed in patients with epilepsy and mental retardation ([@B23]; [@B52]; [@B34]; [@B42]). These mutations found in the coding sequence of collybistin interfere with the somatic and synaptic localization of gephyrin via dominant-negative mechanisms that indirectly affect the distribution and synaptic clustering of GABA~A~R ([@B23]; [@B34]).

The impact that disruption of gephyrin and other scaffolding proteins might have on GABA~A~R function during epileptogenesis remains to be elucidated. If a loss of gephyrin directly impacts the number and function of GABA~A~R at inhibitory synapses, interventions to promote the stability of gephyrin and GABA~A~R might ameliorate the deleterious changes in excitability observed during epileptogenesis and epilepsy. Altered expression of gephyrin has been observed in several pathologies presenting symptomatic seizures, but it is unclear if changes in gephyrin are beneficial or pathologic ([@B32]; [@B69]; [@B29]). Understanding the molecular mechanism(s) behind the dysregulation of scaffolding proteins involved in the regulation of GABA~A~R might provide new insights into the pathologic events that contribute to the generation of spontaneous seizures and might offer new targets to disrupt epileptogenesis and prevent epilepsy.
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